Home
About
Overview
Sharing Data
ORCID
Help
History (1)
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.
FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer. Cancer Med. 2013 Aug; 2(4):545-52.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Agents
Biomarkers
Carcinoma, Renal Cell
Everolimus
Female
Fluorodeoxyglucose F18
Humans
Kidney Neoplasms
Male
Middle Aged
Neoplasm Metastasis
Positron-Emission Tomography
Sirolimus
Treatment Outcome
Tumor Burden
authors with profiles
Walter M. Stadler
Daniel Appelbaum